For the first time in many years, national leaders in the United States are carefully reconsidering how certain regulated substances are classified, with particular attention on plant-based wellness products. As more states adopt medical and adult-use programs, public conversation has shifted. Currently, 38 states support medical access, and 24 allow personal use. This growing state-level framework has encouraged discussion about modernizing national policy. As a result, federal scheduling is now under thoughtful review.
For decades, this plant has been placed in the strictest category under national law, originally based on limited research from the 1970s. Since then, medical programs, patient experiences, and emerging studies have questioned that classification. In 2023, health officials recommended moving it to a more appropriate regulatory category that recognizes medical potential. The proposal is still under consideration by federal agencies. This moment marks a significant turning point in policy evaluation.